Related references
Note: Only part of the references are listed.Lasmiditan and 5-Hydroxytryptamine in the rat trigeminal system; expression, release and interactions with 5-HT1 receptors
Jacob C. A. Edvinsson et al.
JOURNAL OF HEADACHE AND PAIN (2022)
Biological and small molecule strategies in migraine therapy with relation to the calcitonin gene-related peptide family of peptides
Lars Edvinsson et al.
BRITISH JOURNAL OF PHARMACOLOGY (2022)
Identifying New Antimigraine Targets: Lessons from Molecular Biology
Lars Edvinsson et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2021)
Neurokinins and their receptors in the rat trigeminal system: Differential localization and release with implications for migraine pain
Jacob C. A. Edvinsson et al.
MOLECULAR PAIN (2021)
Differences in pituitary adenylate cyclase-activating peptide and calcitonin gene-related peptide release in the trigeminovascular system
Jacob Carl Alexander Edvinsson et al.
CEPHALALGIA (2020)
The fifth cranial nerve in headaches
J. C. A. Edvinsson et al.
JOURNAL OF HEADACHE AND PAIN (2020)
Pharmacological treatment of migraine: CGRP and 5-HT beyond the triptans
Tessa de Vries et al.
PHARMACOLOGY & THERAPEUTICS (2020)
Exploration of purinergic receptors as potential anti-migraine targets using established pre-clinical migraine models
Kristian A. Haanes et al.
CEPHALALGIA (2019)
Diverse TRPV1 responses to cannabinoids
J. Starkus et al.
CHANNELS (2019)
Pathophysiological Mechanisms in Migraine and the Identification of New Therapeutic Targets
Kristian Agmund Haanes et al.
CNS DRUGS (2019)
Joints for joints: cannabinoids in the treatment of rheumatoid arthritis
Torsten Lowin et al.
CURRENT OPINION IN RHEUMATOLOGY (2019)
Cannabis effects on brain structure, function, and cognition: considerations for medical uses of cannabis and its derivatives
Alison C. Burggren et al.
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2019)
Characterization of binding, functional activity, and contractile responses of the selective 5-HT1F receptor agonist lasmiditan
Eloisa Rubio-Beltran et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
C-fibers may modulate adjacent Aδ-fibers through axon-axon CGRP signaling at nodes of Ranvier in the trigeminal system
Jacob C. A. Edvinsson et al.
JOURNAL OF HEADACHE AND PAIN (2019)
Cannabinoid Ligands Targeting TRP Channels
Chante Muller et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2019)
CGRP receptor antagonist activity of olcegepant depends on the signalling pathway measured
Christopher S. Walker et al.
CEPHALALGIA (2018)
PATHOPHYSIOLOGY OF MIGRAINE: A DISORDER OF SENSORY PROCESSING
Peter J. Goadsby et al.
PHYSIOLOGICAL REVIEWS (2017)
RNA Sequencing of Trigeminal Ganglia in Rattus Norvegicus after Glyceryl Trinitrate Infusion with Relevance to Migraine
Sara Hougaard Pedersen et al.
PLOS ONE (2016)
Localization of CGRP, CGRP receptor, PACAP and glutamate in trigeminal ganglion. Relation to the blood-brain barrier
Sajedeh Eftekhari et al.
BRAIN RESEARCH (2015)
A second trigeminal CGRP receptor: function and expression of the AMY1 receptor
Christopher S. Walker et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2015)
Novel endogenous N-acyl amides activate TRPV1-4 receptors, BV-2 microglia, and are regulated in brain in an acute model of inflammation
Siham Raboune et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
NXN-188, a selective nNOS inhibitor and a 5-HT1B/1D receptor agonist, inhibits CGRP release in preclinical migraine models
Deepak K. Bhatt et al.
CEPHALALGIA (2013)
Direct Interactions between Calcitonin-Like Receptor (CLR) and CGRP-Receptor Component Protein (RCP) Regulate CGRP Receptor Signaling
Sophie C. Egea et al.
ENDOCRINOLOGY (2012)
Endocannabinoid Signaling and Synaptic Function
Pablo E. Castillo et al.
NEURON (2012)
Opposing Roles for Cannabinoid Receptor Type-1 (CB1) and Transient Receptor Potential Vanilloid Type-1 Channel (TRPV1) on the Modulation of Panic-Like Responses in Rats
Plinio C. Casarotto et al.
NEUROPSYCHOPHARMACOLOGY (2012)
mRNA expression of 5-hydroxytryptamine 1B, 1D, and 1F receptors and their role in controlling the release of calcitonin gene-related peptide in the rat trigeminovascular system
Dipak V. Amrutkar et al.
PAIN (2012)
TRPV1 receptor blockade is ineffective in different in vivo models of migraine
Oliver Summ et al.
CEPHALALGIA (2011)
Desensitization of Transient Receptor Potential Ankyrin 1(TRPA1) by the TRP Vanilloid 1-Selective Cannabinoid Arachidonoyl-2 Chloroethanolamine
Nikita B. Ruparel et al.
MOLECULAR PHARMACOLOGY (2011)
Inhibitory CB1 and activating/desensitizing TRPV1-mediated cannabinoid actions on CGRP release in rodent skin
Matthias A. Engel et al.
NEUROPEPTIDES (2011)
Role of ionotropic cannabinoid receptors in peripheral antinociception and antihyperalgesia
Armen N. Akopian et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Identification of negative predictors of pain-free response to triptans: Analysis of the eletriptan database
H-C Diener et al.
CEPHALALGIA (2008)
Cannabinoid and vanilloid effects of R(+)-methanandamide in the hemisected meningeal preparation
M. J. M. Fischer et al.
CEPHALALGIA (2007)
Cannabinoid (CB1) receptor activation inhibits trigeminovascular neurons
Simon Akerman et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
The cannabinoid agonist WIN55,212-2 increases intracellular calcium via CB1 receptor coupling to Gq/11 G proteins
JE Lauckner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Discovery of potent, orally available vanilloid receptor-1 antagonists.: Structure-activity relationship of N-aryl cinnamides
EM Doherty et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Modulation of trigeminal sensory neuron activity by the dual cannabinoid-vanilloid agonists anandamide, N-arachidonoyl-dopamine and arachidonyl-2-chloroethylamide
TJ Price et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Anandamide is able to inhibit trigeminal neurons using an in vivo model of trigeminovascular-mediated nociception
S Akerman et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Endovanilloids - Putative endogenous ligands of transient receptor potential vanilloid 1 channels
M van der Stelt et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2004)
The neuronal distribution of cannabinoid receptor type 1 in the trigeminal ganglion of the rat
TJ Price et al.
NEUROSCIENCE (2003)
Capsaicin receptor immunoreactivity in the human trigeminal ganglion
MY Hou et al.
NEUROSCIENCE LETTERS (2002)
Modulation of transmitter release via presynaptic cannabinoid receptors
E Schlicker et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2001)
Gabaergic interneurons are the targets of cannabinoid actions in the human hippocampus
I Katona et al.
NEUROSCIENCE (2000)
The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)
D Smart et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Share Paper
